MedPolonia
Poznan 60-693
2 studies enrolling now · 6 studies all time
What they study most
Multiple Sclerosis, Non-small Cell Lung Cancer (NSCLC), Relapsing Multiple Sclerosis, Sjogren's Syndrome, Triple Negative Breast Cancer
Studies at this site
- Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer — Recruiting now
- A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis — Recruiting now
- Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
- A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
- A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome — Completed